Institute for Human Neuroscience seeks participants for vital Alzheimer’s research
Candidates must be 55+ with diagnosis of AD or mild cognitive impairment
Special for the Institute for Human Neuroscience
Updated
As part of the study, participants will receive a MEG scan (as seen above). The Institute for Human Neuroscience is a leader in MEG imaging, houses the world's most advanced MEG systems, and is the only institute globally that has two of these identical systems.
The Institute for Human Neuroscience (IHN) at Boys Town National Research Hospital in Omaha is seeking individuals 55 years and older who have been diagnosed with Alzheimer’s disease (AD) or mild cognitive impairment (MCI) to participate in a research study.
According to the National Institute of Health, a positive scan can lead to appropriate treatments that have been shown to slow down the progression of Alzheimer’s.
As part of the study, participants will receive a MEG scan (as seen above). The Institute for Human Neuroscience is a leader in MEG imaging, houses the world's most advanced MEG systems, and is the only institute globally that has two of these identical systems.
According to the National Institute of Health, a positive scan can lead to appropriate treatments that have been shown to slow down the progression of Alzheimer’s.
